Who Owns Bio-Rad Laboratories Stock?
NYSE: BIOIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 91.60%
- Institutions (% of float)
- 109.58%
- Held by insiders
- 16.41%
- Institutional holders
- 530
- Institutions 83.6%
- Insiders 16.4%
- Public and other 0.0%
Who owns Bio-Rad Laboratories stock?
Institutional investors own about 91.6% of Bio-Rad Laboratories's shares, spread across 530 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 16.41% of BIO.
The largest institutional holders are First Eagle Investment Management, LLC (12.02%), Blackrock Inc. (7.84%) and Dimensional Fund Advisors LP (4.36%). Together, the top 10 institutions control 45.3% of shares outstanding. In their latest filings, 6 of the top 10 institutions increased their BIO positions and 4 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of BIO
| Institution | Shares | % Held | Change |
|---|---|---|---|
| First Eagle Investment Management, LLC | 2.61M | 12.02% | +0.1% |
| Blackrock Inc. | 1.70M | 7.84% | +1.1% |
| Dimensional Fund Advisors LP | 944.55K | 4.36% | -13.3% |
| Vanguard Capital Management LLC | 826.97K | 3.81% | -0.5% |
| Ariel Investments, LLC | 816.75K | 3.77% | +3.9% |
| Vanguard Portfolio Management LLC | 816.20K | 3.77% | -1.6% |
| Earnest Partners LLC | 580.75K | 2.68% | -1.4% |
| State Street Corporation | 571.76K | 2.64% | +2.2% |
| Bank of America Corporation | 490.41K | 2.26% | +10.2% |
| Capital World Investors | 462.46K | 2.13% | +2.8% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of BIO
| Fund | Shares | % Held |
|---|---|---|
| First Eagle Funds-First Eagle Global Fund | 1.88M | 8.67% |
| SmallCap World Fund Inc | 881.72K | 4.07% |
| iShares Trust-iShares Core S&P Mid-Cap ETF | 630.80K | 2.91% |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 584.78K | 2.70% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund | 423.19K | 1.95% |
| Ariel Investment Trust-Ariel Fund | 349.27K | 1.61% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Small Cap Value Portfolio | 291.33K | 1.34% |
| MFS Series Trust IV-MFS Mid Cap Growth Fund | 277.00K | 1.28% |
| VANGUARD INDEX FUNDS-Vanguard Small-Cap Value Index Fund | 267.97K | 1.24% |
| FPA FUNDS TRUST-FPA Crescent Fund | 244.38K | 1.13% |
Frequently asked questions
Who is the largest shareholder of Bio-Rad Laboratories?
First Eagle Investment Management, LLC is the largest institutional shareholder of BIO, owning 12.02% of shares outstanding (2.61M shares) as of its latest 13F filing.
What percentage of Bio-Rad Laboratories is owned by institutions?
Institutions own about 91.6% of BIO shares and 109.6% of the public float.
How much of Bio-Rad Laboratories do insiders own?
Insiders, such as officers and directors, own about 16.41% of BIO shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.